Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case
A federal judge ordered Janssen to pay $1.64 billion after a jury found it liable in a whistleblower lawsuit for illegally promoting Prezista and Intelence.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Intelence
since
auto-detected in 2 stories
8 months ago
page 1 of 1